Related references
Note: Only part of the references are listed.Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management
Andriana Papaioannou et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
Ian D. Pavord et al.
ERJ OPEN RESEARCH (2022)
EAACI Biologicals Guidelines-Recommendations for severe asthma
Ioana Agache et al.
ALLERGY (2021)
Type 2-low asthma phenotypes by integration of sputum transcriptomics and serum proteomics
Nazanin Zounemat Kermani et al.
ALLERGY (2021)
Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
Olaf Holz et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic COPD
Michael Fricker et al.
ALLERGY (2021)
Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases
Wadah Ibrahim et al.
THORAX (2021)
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program
Annette T. Hastie et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Clinical evaluation of type 2 disease status in a real-world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts
Adnan Azim et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Eosinophilic and Noneosinophilic Asthma An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
Liam G. Heaney et al.
CHEST (2021)
Aeroallergen sensitization for detecting asthma in primary care: A diagnostic test accuracy study
Janwillem W. H. Kocks et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Beclometasone dipropionate/formoterol maintenance and reliever therapy asthma exacerbation benefit increases with blood eosinophil level
Guy Brusselle et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Eosinophils in Health and Disease: A State-of-the-Art Review
Michael E. Wechsler et al.
MAYO CLINIC PROCEEDINGS (2021)
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
William W. Busse et al.
LANCET RESPIRATORY MEDICINE (2021)
Recent Insights into the Management of Inflammation in Asthma
Hitasha Rupani et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
A Comprehensive Analysis of the Stability of Blood Eosinophil Levels
Bradley E. Chipps et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Immunobiology of Steroid-Unresponsive Severe Asthma
Courtney Lynn Marshall et al.
FRONTIERS IN ALLERGY (2021)
Mechanisms and therapeutic strategies for non-T2 asthma
Eric Sze et al.
ALLERGY (2020)
Different endotypes and phenotypes drive the heterogeneity in severe asthma
P. Jane McDowell et al.
ALLERGY (2020)
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Fernando Holguin et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Characterization of Severe Asthma Worldwide Data From the International Severe Asthma Registry
Eileen Wang et al.
CHEST (2020)
IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids
F. Nicole Dijk et al.
ALLERGY (2020)
ORMDL3 but not neighboring 17q21 gene LRRC3C is expressed in human lungs and lung cells of asthmatics
Gyu Young Hur et al.
ALLERGY (2020)
International Severe Asthma Registry Mission Statement
G. Walter Canonica et al.
CHEST (2020)
A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents
Nathanael Lemonnier et al.
ALLERGY (2020)
iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma
Juan Jose Nieto-Fontarigo et al.
ALLERGY (2020)
Predictive factors of response to inhaled corticosteroids in newly diagnosed asthma A real-world observational study
Hyo-In Rhyou et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
T2-Low Asthma: Overview and Management Strategies
Anne M. Fitzpatrick et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Cross-sectional biomarker comparisons in asthma monitoring using a longitudinal design: The eNose premise
Mahmoud I. Abdel-Aziz et al.
ALLERGY (2020)
Integration of metagenomics-metabolomics reveals specific signatures and functions of airway microbiota in mite-sensitized childhood asthma
Chih-Yung Chiu et al.
ALLERGY (2020)
Advances and recent developments in asthma in 2020
Lacin Cevhertas et al.
ALLERGY (2020)
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
Heimo Breiteneder et al.
ALLERGY (2020)
Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review
Adam M. Peel et al.
RESPIRATORY MEDICINE (2020)
2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group
Michelle M. Cloutier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation
Omar Tliba et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics
Kentaro Takahashi et al.
JOURNAL OF ASTHMA (2019)
Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Merin E. Kuruvilla et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
Ioana Agache et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Toward clinically applicable biomarkers for asthma: An EAACI position paper
Zuzana Diamant et al.
ALLERGY (2019)
The importance of social networks-An ecological and evolutionary framework to explain the role of microbes in the aetiology of allergy and asthma
Jens Walter et al.
ALLERGY (2019)
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018
Sven F. Seys et al.
ALLERGY (2019)
What did we learn from multiple omics studies in asthma?
Olga Ivanova et al.
ALLERGY (2019)
Periostin: An emerging biomarker for allergic diseases
Kenji Izuhara et al.
ALLERGY (2019)
Thinking bigger: How early-life environmental exposures shape the gut microbiome and influence the development of asthma and allergic disease
Hind Sbihi et al.
ALLERGY (2019)
Exhaled volatile organic compounds in adult asthma: a systematic review
Adnan Azim et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Phenotypes and endotypes of adult asthma: Moving toward precision medicine
Ravdeep Kaur et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Dietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation
Gavin Lewis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
David B. Price et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2019)
Neutrophilic asthma: welcome back!
Peter G. Gibson et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Bacterial secretion of histamine within the gut influences immune responses within the lung
Weronika Barcik et al.
ALLERGY (2019)
T2-high in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
Stelios Pavlidis et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
The upper-airway microbiota and loss of asthma control among asthmatic children
Yanjiao Zhou et al.
NATURE COMMUNICATIONS (2019)
Interleukin-5 in the Pathophysiology of Severe Asthma
Corrado Pelaia et al.
FRONTIERS IN PHYSIOLOGY (2019)
Distinctive lung function trajectories from age 10 to 26years in men and women and associated early life risk factors - a birth cohort study
Wilfried Karmaus et al.
RESPIRATORY RESEARCH (2019)
Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
Charlene M. Prazma et al.
RESPIRATORY RESEARCH (2019)
Step-down of inhaled corticosteroids in non-eosinophilic asthma: A prospective trial in real life
S. Demarche et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Predictors of accelerated decline in lung function in adult-onset asthma
Hanneke Coumou et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology
Steven L. Taylor et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
After asthma: redefining airways diseases
Ian D. Pavord et al.
LANCET (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antibiotics as Instigators of Microbial Dysbiosis: Implications for Asthma and Allergy
Tomasz P. Wypych et al.
TRENDS IN IMMUNOLOGY (2018)
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial
David B. Price et al.
LANCET RESPIRATORY MEDICINE (2018)
Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studies
Danielle C. M. Belgrave et al.
LANCET RESPIRATORY MEDICINE (2018)
Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
J. Mark FitzGerald et al.
LANCET RESPIRATORY MEDICINE (2018)
Time of Day Affects Eosinophil Biomarkers in Asthma: Implications for Diagnosis and Treatment
Hannah J. Durrington et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function
Adel H. Mansur et al.
RESPIRATORY MEDICINE (2018)
Validation of ATS clinical practice guideline cut-points for FeNO in asthma
Maria Jeppegaard et al.
RESPIRATORY MEDICINE (2018)
Non-eosinophilic asthma: current perspectives
Ignacio Esteban-Gorgojo et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
FeNO-based asthma management results in faster improvement of airway hyperresponsiveness
Katrine Feldballe Bernholm et al.
ERJ OPEN RESEARCH (2018)
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
E. Jensen-Jarolim et al.
ALLERGY (2018)
Severe eosinophilic asthma: a roadmap to consensus
Roland Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Precision medicine in airway diseases: moving to clinical practice
Alvar Agusti et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
Ildiko Horvath et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Biomarkers for severe eosinophilic asthma
Steven W. Yancey et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
Peter G. Gibson et al.
LANCET (2017)
Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?
Ioana Agache et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2017)
Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?
Anne M. Fitzpatrick et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Asthma Exacerbations: Pathogenesis, Prevention, and Treatment
Jamee R. Castillo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma
P. Brinkman et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma
Makoto Hoshino et al.
RESPIROLOGY (2016)
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels A Randomized Phase 3 Study
Leif Bjermer et al.
CHEST (2016)
Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease
R. Caswell-Smith et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Advances in asthma 2015: Across the lifespan
Andrew H. Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Histamine-secreting microbes are increased in the gut of adult asthma patients
Weronika Barcik et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Individualized therapy for persistent asthma in young children
Anne M. Fitzpatrick et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Asthma phenotypes in inner-city children
Edward M. Zoratti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation
Kei E. Fujimura et al.
NATURE MEDICINE (2016)
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma
M. J. McGeachie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
Hector G. Ortega et al.
LANCET RESPIRATORY MEDICINE (2016)
The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside
Ioana Agache et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2015)
The airway microbiome in patients with severe asthma: Associations with disease features and severity
Yvonne J. Huang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis
Daniel A. Korevaar et al.
LANCET RESPIRATORY MEDICINE (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
Christopher E. Brightling et al.
LANCET RESPIRATORY MEDICINE (2015)
External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma
A. H. Wagener et al.
THORAX (2015)
Revisiting the role of exhaled nitric oxide in asthma
Fabio L. M. Ricciardolo
CURRENT OPINION IN PULMONARY MEDICINE (2014)
Effects of weight loss on asthma control in obese patients with severe asthma
Servulo Azevedo Dias-Junior et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Florence Nicole Schleich et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study
Nicola A. Hanania et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects
Annette T. Hastie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Systemic Inflammation Is Associated with Differential Gene Expression and Airway Neutrophilia in Asthma
Juan-juan Fu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2013)
Relationship between airway neutrophilia and ageing in asthmatics and non-asthmatics
Collin R. Brooks et al.
RESPIROLOGY (2013)
Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis
Meghan B. Azad et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
The Utility of Fractional Exhaled Nitric Oxide Suppression in the Identification of Nonadherence in Difficult Asthma
Diarmuid M. McNicholl et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
Seung Y. Chu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Guiquan Jia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Asthma phenotypes: the evolution from clinical to molecular approaches
Sally E. Wenzel
NATURE MEDICINE (2012)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Determinants of Exhaled Breath Condensate pH in a Large Population With Asthma
Lei Liu et al.
CHEST (2011)
Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial
Heather Powell et al.
LANCET (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers
Georgios Hillas et al.
RESPIROLOGY (2011)
Allergen-specific IgE as a biomarker of exposure plus sensitization in inner-city adolescents with asthma
E. C. Matsui et al.
ALLERGY (2010)
Exhaled Nitric Oxide and Exhaled Breath Condensate pH in Severe Refractory Asthma
Eleni Tseliou et al.
CHEST (2010)
Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: A random-sample population study
Asger Sverrild et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Increased serum IL-17 is an independent risk factor for severe asthma
Ioana Agache et al.
RESPIRATORY MEDICINE (2010)
Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma
Mike Berry et al.
THORAX (2007)
Predicting and evaluating response to omalizumab in patients with severe allergic asthma
J. Bousquet et al.
RESPIRATORY MEDICINE (2007)
Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE
Roberto de Marco et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Total serum immunoglobulin E levels in a case-control study in asthmatic/allergic patients, their family members, and healthy subjects from India
S. Sharma et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Effects of smoking cessation on lung function and airway inflammation in smokers with asthma
Rekha Chaudhuri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals
Go Takayama et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Determining asthma treatment by monitoring sputum cell counts:: effect on exacerbations
L Jayaram et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma
L Borish et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
RH Green et al.
LANCET (2002)
Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness
R Louis et al.
ALLERGY (2002)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation?
KF Chung
EUROPEAN RESPIRATORY JOURNAL (2000)
Induced sputum cell counts in healthy adults
J Belda et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
